Cargando…

Lung-molGPA Index Predicts Survival Outcomes of Non-Small-Cell Lung Cancer Patients with Synchronous or Metachronous Brain Metastases

BACKGROUND: Graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA) for brain metastases is a powerful prognostic tool. However, it has not been validated for non-small-cell lung cancer (NSCLC) patients with synchronous or metachronous brain metastases. METHODS: A total of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Kaiyan, Zhang, Fanrong, Fan, Yun, Cheng, Guoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481286/ https://www.ncbi.nlm.nih.gov/pubmed/32943887 http://dx.doi.org/10.2147/OTT.S255478

Ejemplares similares

Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA)
por: Nieder, Carsten, et al.
Publicado: (2017)

Predictors of Lung Adenocarcinoma With Leptomeningeal Metastases: A 2022 Targeted-Therapy-Assisted molGPA Model
por: Zhang, Milan, et al.
Publicado: (2022)

Outcomes after stereotactic radiosurgery of brain metastases in patients with malignant melanoma and validation of the melanoma molGPA
por: Kessel, K. A., et al.
Publicado: (2021)

Estimating Survival in Patients with Non-Small-Cell Lung Cancer and Brain Metastases: A Verification of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
por: Li, Ji, et al.
Publicado: (2021)

Validation of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)
por: Nieder, Carsten, et al.
Publicado: (2018)

A modified melanoma-molGPA scoring model: assessment of survival after and efficacy of different radiotherapy modalities in patients with melanoma brain metastases
por: Wu, Qian, et al.
Publicado: (2023)

Applicability of the adjusted graded prognostic assessment for lung cancer with brain metastases using molecular markers (Lung‐molGPA) in a Chinese cohort: A retrospective study of multiple institutions
por: Zhang, Tingyou, et al.
Publicado: (2020)

Surgical resection of synchronous and metachronous lung and liver metastases of colorectal cancers
por: Jeong, Shinseok, et al.
Publicado: (2017)

Mutational signatures of synchronous and metachronous brain metastases from lung adenocarcinoma
por: Chen, Jianing, et al.
Publicado: (2023)

Incidence and Survival in Synchronous and Metachronous Liver Metastases From Colorectal Cancer
por: Reboux, Noémi, et al.
Publicado: (2022)

The different clonal origins of metachronous and synchronous metastases
por: Gofrit, Ofer N., et al.
Publicado: (2023)

LMAP-04 CHOOSING WISELY BETWEEN RADIOTHERAPY DOSE-FRACTIONATION SCHEDULES: THE MOLECULAR GRADED PROGNOSTIC ASSESSMENT (MOLGPA) FOR ELDERLY GLIOBLASTOMA (EGBM-MOLGPA)
por: Lee, Hye In, et al.
Publicado: (2023)

Long-term Survival after Surgical Treatment of Metachronous Bilateral Adrenal Metastases of Non-small Cell Lung Carcinoma
por: Taira, Naohiro, et al.
Publicado: (2014)

Immune microenvironment features and efficacy of PD‐1/PD‐L1 blockade in non‐small cell lung cancer patients with EGFR or HER2 exon 20 insertions
por: Chen, Kaiyan, et al.
Publicado: (2020)

Mutational status of synchronous and metachronous tumor samples in patients with metastatic non-small-cell lung cancer
por: Quéré, Gilles, et al.
Publicado: (2016)

Clinicopathologic and Prognostic Association of GRP94 Expression in Colorectal Cancer with Synchronous and Metachronous Metastases
por: Yun, Sumi, et al.
Publicado: (2021)

Metachronous gastric metastasis from lung primary, with synchronous pancreatic neuroendocrine carcinoma
por: El Hajj, Ihab I., et al.
Publicado: (2018)

Multiple metachronous and synchronous malignancies with lung and thorax involvement. Report of two cases
por: Sapalidis, Konstantinos, et al.
Publicado: (2018)

Renal Cell Carcinoma with Synchronous Metastasis to the Calcaneus and Metachronous Metastases to the Ovary and Gallbladder
por: Decoene, Jasper, et al.
Publicado: (2011)

Synchronous and Metachronous Peritoneal Metastases in Patients with Left-Sided Obstructive Colon Cancer
por: Veld, Joyce Valerie, et al.
Publicado: (2020)

Multiple Gamma Knife Radiosurgery for Multiple Metachronous Brain Metastases Associated with Lung Cancer : Survival Time
por: Kim, Hyung-Seok, et al.
Publicado: (2012)

Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer
por: Fleckenstein, Jochen, et al.
Publicado: (2016)

Outcomes of Adolescent and Adult Patients with Lung Metastatic Osteosarcoma and Comparison of Synchronous and Metachronous Lung Metastatic Groups
por: Gok Durnali, Ayse, et al.
Publicado: (2016)

Synchronous and metachronous colorectal liver metastases: impact of primary tumor location on patterns of recurrence and survival after hepatic resection
por: Garajova, Ingrid, et al.
Publicado: (2021)

Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases
por: Mekenkamp, L J M, et al.
Publicado: (2010)

Estimating changes in the rate of synchronous and metachronous metastases over time: Analysis of SEER data
por: Yilmaz, Ugur, et al.
Publicado: (2017)

Differences in clinical characteristics and mutational pattern between synchronous and metachronous colorectal liver metastases
por: Zheng, Peng, et al.
Publicado: (2018)

Analysis of Prognostic Factors for Resected Synchronous and Metachronous Liver Metastases from Colorectal Cancer
por: Bartolini, Ilenia, et al.
Publicado: (2018)

Two rare cases of synchronous and metachronous colonic metastases in patients with advanced gastric cancer
por: Su, Wei-Chih, et al.
Publicado: (2018)

Long-term survival of a patient with small cell carcinoma of the stomach with metachronous lung metastases treated by multimodal therapy: a case report
por: Aoyagi, Keishiro, et al.
Publicado: (2015)

Integrated genomic and DNA methylation analysis of patients with advanced non-small cell lung cancer with brain metastases
por: Xu, Yanjun, et al.
Publicado: (2021)

Concurrent Androgen Deprivation Therapy for Prostate Cancer Improves Survival for Synchronous or Metachronous Non-Small Cell Lung Cancer: A SEER–Medicare Database Analysis
por: Nazha, Bassel, et al.
Publicado: (2022)

Synchronous and metachronous liver metastases in patients with colorectal cancer—towards a clinically relevant definition
por: Engstrand, Jennie, et al.
Publicado: (2019)

Prediction of Microscopic Metastases in Patients with Metachronous Oligo-Metastases after Curative Treatment of Non-Small Cell Lung Cancer: A Microsimulation Study
por: Wolff, Henri B., et al.
Publicado: (2021)

Concurrent brain radiotherapy and EGFR-TKI may improve intracranial metastases control in non-small cell lung cancer and have survival benefit in patients with low DS-GPA score
por: Liu, Yongmei, et al.
Publicado: (2017)

Synchronous Papillary Carcinoma and Hemangiopericytoma with Lung Metastases
por: Malagutti, Nicola, et al.
Publicado: (2013)

Characteristics and Survival of Breast Cancer Patients with Multiple Synchronous or Metachronous Primary Cancers
por: Lee, Janghee, et al.
Publicado: (2015)

Survival Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Patients with Synchronous Versus Metachronous Onset of Peritoneal Metastases of Colorectal Carcinoma
por: Dietz, Michelle V., et al.
Publicado: (2022)

Utility of Genomic Analysis in Differentiating Synchronous and Metachronous Lung Adenocarcinomas from Primary Adenocarcinomas with Intrapulmonary Metastasis()()
por: Saab, Jad, et al.
Publicado: (2017)

The Clinical Implication of Cancer-Associated Microvasculature and Fibroblast in Advanced Colorectal Cancer Patients with Synchronous or Metachronous Metastases
por: Kwak, Yoonjin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ff29shpevuabgodcu7kqf9rmbl